Glo1-flox Mouse
Common Name
Glo1-flox
제품 ID
S-CKO-00802
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-109801-Glo1-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Glo1-flox Mouse (카탈로그 번호 S-CKO-00802)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Glo1-flox
품종 계통계통 ID
CKOCMP-109801-Glo1-B6J-VA
유전자명
제품 ID
S-CKO-00802
유전자 별칭
GLY1, Qglo, Glo-1, Glo-1r, Glo-1s, Glo1-r, Glo1-s, 0610009E22Rik, 1110008E19Rik, 2510049H23Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 17
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000236335
NCBI 전사체 ID
NM_025374
타겟 영역
Exon 4
유효 영역 크기
~0.6 kb
유전자 연구 개요
Glo1, also known as Glyoxalase I, is a cytosolic protein expressed in all mammalian cells. Its main function is the detoxification of methylglyoxal (MG), a potent precursor of advanced glycation end-products (AGEs), and it is involved in the cellular glycolysis pathway [3,4]. By regulating MG, Glo1 impacts various biological processes and is associated with multiple diseases, highlighting its biological importance [1].
Modulation of Glo1 activity has been shown to regulate anxiety-like behavior and seizure-susceptibility in mice, suggesting it as a novel target for neuropsychiatric and anti-epileptic drug development [1]. In hepatocellular carcinoma (HCC), Glo1 is overexpressed, activates the cell cycle pathway, and promotes cell proliferation and migration, making it a promising therapeutic target [2]. In glioma, high Glo1 expression is correlated with poor prognosis and enhances tumor cell proliferation, migration, and invasion [4]. In Escherichia coli, Glo1 contributes to drug resistance by inducing PER-type of extended-spectrum β-lactamases [5]. In human skeletal muscle, loss of NAMPT and SIRT2 attenuates Glo1 expression and activity [6]. In melanoma, genomic Glo1 deletion modulates TXNIP expression, glucose metabolism, and redox homeostasis while accelerating tumor growth [7]. In bladder cancer, miR-205-3p suppresses cancer progression via Glo1-mediated P38/ERK activation [8]. In HCC, Glo1 genetic amplification is associated with cell proliferation and survival, and interfering Glo1 expression inhibits tumor growth [9]. In a Chinese population, Glo1 SNPs are associated with gestational diabetes mellitus susceptibility [10].
In conclusion, Glo1 plays essential roles in multiple biological processes and diseases. Through various in vivo and in vitro models, its functions in neuropsychiatric disorders, cancers, bacterial drug resistance, and diabetes-related conditions have been revealed. These findings provide valuable insights into disease mechanisms and potential therapeutic strategies targeting Glo1.
References:
1. McMurray, Katherine M J, Distler, Margaret G, Sidhu, Preetpal S, Palmer, Abraham A, Plant, Leigh D. . Glo1 inhibitors for neuropsychiatric and anti-epileptic drug development. In Biochemical Society transactions, 42, 461-7. doi:10.1042/BST20140027. https://pubmed.ncbi.nlm.nih.gov/24646261/
2. Zhang, Yao, Tang, Xiaolong, Liu, Lin, Yao, Lei, Du, Fukuan. 2024. GLO1 regulates hepatocellular carcinoma proliferation and migration through the cell cycle pathway. In BMC cancer, 24, 1297. doi:10.1186/s12885-024-12927-x. https://pubmed.ncbi.nlm.nih.gov/39434012/
3. Wortmann, Markus, Peters, Andreas S, Hakimi, Maani, Böckler, Dittmar, Dihlmann, Susanne. . Glyoxalase I (Glo1) and its metabolites in vascular disease. In Biochemical Society transactions, 42, 528-33. doi:10.1042/BST20140003. https://pubmed.ncbi.nlm.nih.gov/24646273/
4. Tian, Xiaomin, Wang, Yu, Ding, Xue, Cheng, Wei. 2019. High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients. In Journal of neurosurgical sciences, 66, 228-233. doi:10.23736/S0390-5616.19.04805-7. https://pubmed.ncbi.nlm.nih.gov/31738028/
5. Ma, He, Lai, Bingjie, Zan, Chunfang, Zhu, Xinran, Wang, Ke. 2022. GLO1 Contributes to the Drug Resistance of Escherichia coli Through Inducing PER Type of Extended-Spectrum β-Lactamases. In Infection and drug resistance, 15, 1573-1586. doi:10.2147/IDR.S358578. https://pubmed.ncbi.nlm.nih.gov/35414749/
6. Miranda, Edwin R, Varshney, Pallavi, Mazo, Corey E, Ludlow, Andrew T, Haus, Jacob M. 2024. Loss of NAMPT and SIRT2 but not SIRT1 attenuate GLO1 expression and activity in human skeletal muscle. In Redox biology, 75, 103300. doi:10.1016/j.redox.2024.103300. https://pubmed.ncbi.nlm.nih.gov/39142179/
7. Jandova, Jana, Wondrak, Georg T. 2020. Genomic GLO1 deletion modulates TXNIP expression, glucose metabolism, and redox homeostasis while accelerating human A375 malignant melanoma tumor growth. In Redox biology, 39, 101838. doi:10.1016/j.redox.2020.101838. https://pubmed.ncbi.nlm.nih.gov/33360689/
8. Zhenhai, Zou, Qi, Cheng, Shuchao, Zhang, Beibei, Liu, Yuanyuan, Guo. 2023. MiR-205-3p suppresses bladder cancer progression via GLO1 mediated P38/ERK activation. In BMC cancer, 23, 956. doi:10.1186/s12885-023-11175-9. https://pubmed.ncbi.nlm.nih.gov/37814205/
9. Zhang, Shirong, Liang, Xiaodong, Zheng, Xiaoliang, Wang, Bing, Ma, Shenglin. 2014. Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma. In International journal of clinical and experimental pathology, 7, 2079-90. doi:. https://pubmed.ncbi.nlm.nih.gov/24966916/
10. Zeng, Qiaoli, Yang, Taili, Wei, Wenfeng, Huang, Jinzhi, Guo, Runmin. 2023. Association between GLO1 variants and gestational diabetes mellitus susceptibility in a Chinese population: a preliminary study. In Frontiers in endocrinology, 14, 1235581. doi:10.3389/fendo.2023.1235581. https://pubmed.ncbi.nlm.nih.gov/38027126/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
